Foundation Fighting Blindness Retinal Degeneration Fund

Director at IRD

Sold, on record
$18.8M
Dollars the filings state
Form 4 sales
3
Latest Sep 30, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • IRDOpus Genetics, Inc.Director

Sales by reason

0
Routine
0
Plan not stated
1
No plan
2
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, every sale on record.

Sales chart range

Timeline

  1. 1 Form 4 sale IRDUnusual
    Dec 9, 2025 2025

    Sold 4M shares at $2.15 ($8.6M)

    Foundation Fighting Blindness Retinal Degeneration Fund, Director

    No 10b5-1 planSold 42.1% of holdings ($20.4M position)5.5M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale IRDUnusual
    May 18, 2026 +160 days

    Sold 1.7M shares at $4.35 ($7.4M)

    Foundation Fighting Blindness Retinal Degeneration Fund, Director

    No 10b5-1 planSold 31% of holdings ($23.9M position)3.8M shares leftFiling

  3. 3 Form 4 sale IRDNo plan
    Sep 30, 2026 +135 days

    Sold 556,000 shares at $4.96 ($2.8M)

    Foundation Fighting Blindness Retinal Degeneration Fund, Director

    No 10b5-1 planSold 14.7% of holdings ($18.8M position)3.2M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Foundation Fighting Blindness Retinal Degeneration Fund
Source
Sep 30, 2026Oct 2, 2026IRDDirectorForm 4 sale556,000$2.8M14.7%No planSEC
May 18, 2026May 20, 2026IRDDirectorForm 4 sale1.7M$7.4M31.0%UnusualSEC
Dec 9, 2025Dec 11, 2025IRDDirectorForm 4 sale4M$8.6M42.1%UnusualSEC